Transformation Atlas
Research-Based Intelligence
Daily Report

Opportunity Finder — Daily Report

As of 2026-07-10 · 82 opportunities flagged (top-tier business quality, elevated market doubt).

News overlay · as of 2026-07-09, carried from the last weekly run (recomputes weekly)

Top 10 — quality × doubt

#CompanySectorQual %ileDoubtRecommended next step
1ADBE
Adobe Inc.
Technology97.4%0.98HOLD OFF — CONFIRM THE TURN
NEWS CONSTRUCTIVE Signals: cheap vs history · off highs · below trend · near low · turning up
2LULU
Lululemon Athletica Inc.
Consumer Cyclical87.2%0.99BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT INSIDER BUYING Signals: cheap vs history · off highs · below trend · near low
3ZTS
Zoetis Inc.
Healthcare92.8%1.00RECONSIDER — DOUBT MAY BE EARNED
DOUBT EARNED INSIDERS BUYING Signals: cheap vs history · off highs · below trend · near low
4CPRT
Copart, Inc.
Industrials90.8%0.92BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low
5ADSK
Autodesk, Inc.
Technology87.4%0.85BUY CANDIDATE — WORTH A CLOSE LOOK
DOUBT = SENTIMENT INSIDERS BUYING Signals: cheap vs history · off highs · below trend · near low
6IDXX
IDEXX Laboratories, Inc.
Healthcare98.2%0.77HOLD OFF — CONFIRM THE TURN
DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low · turning up
7INTU
Intuit Inc.
Technology78.8%1.00RESEARCH THE CAUSE FIRST
DEBATED Signals: cheap vs history · off highs · below trend · near low
8ISRG
Intuitive Surgical, Inc.
Healthcare91.2%0.78BUY CANDIDATE — WORTH A CLOSE LOOK
NEWS CONSTRUCTIVE INSIDERS SELLING Signals: cheap vs history · off highs · below trend · near low
9CLX
The Clorox Company
Consumer Defensive85.8%0.82HOLD OFF — CONFIRM THE TURN
DOUBT = SENTIMENT INSIDER BUYING Signals: cheap vs history · off highs · below trend · near low · turning up
10AOS
A. O. Smith Corporation
Industrials89.8%0.82HOLD OFF — CONFIRM THE TURN
DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low · turning up
⇩ Full report (PDF) ⇩ Ranked CSV ⇩ Data (JSON) How these are ranked
Per-name detail

The 10 companies, in depth

1. ADBE Adobe Inc.

NEWS CONSTRUCTIVE

Software - Application · adj close 222.65 (div-adj)

Quality 97.4% pctile
Market doubt 0.98 / 1.00

News read — the news is constructive: HSBC upgrade on valuation reset; analyst lifts Adobe on fundamentals; no hard negatives present.. Lifts the opportunity score to 1.00 (from 0.96).

Business quality fingerprint

Returns
ROIC36.7%
ROE61.3%
Gross profitability71.4%
Margins
Gross margin88.6%
Operating margin36.6%
FCF margin41.4% (FCF+)
Growth (3-yr)
Revenue CAGR10.5%
EPS CAGR18.2%
Balance sheet
Net debt / EBITDA0.12
Share count (5-yr)-11.2%
Quality score0.88 · 97.4% pctile

What it does

Adobe Inc. stands as a prominent global software provider, delivering a diverse range of solutions. Its operations are structured into three primary business divisions: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment empowers individuals, teams, and enterprises to generate, disseminate, and amplify various forms of content through its array of products and services, including the cloud-native Document Cloud platform.

Doubt & mispricing

The market doubts it (score 0.98): trading cheap versus its own multi-year range; down 40% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.

Recommended next step

HOLD OFF — CONFIRM THE TURN

The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

2. LULU Lululemon Athletica Inc.

DOUBT = SENTIMENT

Apparel - Retail · adj close 116.51 (div-adj)

Quality 87.2% pctile
Market doubt 0.99 / 1.00

News read — the doubt looks like sentiment, not damage: Analyst price-target cut with no earnings miss, guidance cut, or demand decline. Pure valuation pullback.. Lifts the opportunity score to 0.95 (from 0.86).

Business quality fingerprint

Returns
ROIC22.7%
ROE31.8%
Gross profitability74.3%
Margins
Gross margin56.6%
Operating margin19.9%
FCF margin8.3% (FCF+)
Growth (3-yr)
Revenue CAGR11.0%
EPS CAGR25.7%
Balance sheet
Net debt / EBITDA-0.00
Share count (5-yr)-8.6%
Quality score0.76 · 87.2% pctile

What it does

Lululemon Athletica Inc., alongside its subsidiaries, specializes in the design, global distribution, and retail of athletic apparel and accessories for both women and men. Its business operations are structured into two main divisions: company-owned retail establishments and direct-to-consumer sales. The firm's offerings encompass a range of clothing such as pants, shorts, tops, and jackets, all crafted for promoting a healthy lifestyle and facilitating athletic endeavors. These activities span yoga, running, training, and other physically demanding pursuits.

Doubt & mispricing

The market doubts it (score 0.99): trading cheap versus its own multi-year range; down 51% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -51.2% (skim recent headlines + the last earnings call).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

3. ZTS Zoetis Inc.

DOUBT EARNED

Drug Manufacturers - General · adj close 75.82 (div-adj)

Quality 92.8% pctile
Market doubt 1.00 / 1.00

News read — the doubt looks earned: Securities class action lawsuit filed against Zoetis shareholders; hard negative catalyst per decision rule #1.. Cuts the opportunity score to 0.88 (from 0.93).

Business quality fingerprint

Returns
ROIC21.5%
ROE80.2%
Gross profitability43.1%
Margins
Gross margin70.5%
Operating margin38.0%
FCF margin24.1% (FCF+)
Growth (3-yr)
Revenue CAGR5.4%
EPS CAGR10.3%
Balance sheet
Net debt / EBITDA1.76
Share count (5-yr)-6.9%
Quality score0.81 · 92.8% pctile

What it does

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.

Doubt & mispricing

The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 52% from its 1-year high, below its 200-day line.

Recommended next step

RECONSIDER — DOUBT MAY BE EARNED

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -51.5% (skim recent headlines + the last earnings call).

Recent news points to realized deterioration, not just sentiment — the cheapness may be a value trap. Confirm the cause before acting (base read would say ‘Buy Candidate’).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

4. CPRT Copart, Inc.

DOUBT = SENTIMENT

Specialty Business Services · adj close 28.33 (div-adj)

Quality 90.8% pctile
Market doubt 0.92 / 1.00

News read — the doubt looks like sentiment, not damage: Leadership transition and valuation pullback; no earnings miss, guidance cut, or fundamental deterioration.. Lifts the opportunity score to 0.88 (from 0.83).

Business quality fingerprint

Returns
ROIC14.7%
ROE16.9%
Gross profitability20.8%
Margins
Gross margin45.2%
Operating margin36.5%
FCF margin26.5% (FCF+)
Growth (3-yr)
Revenue CAGR9.9%
EPS CAGR12.1%
Balance sheet
Net debt / EBITDA-1.27
Share count (5-yr)+1.7%
Quality score0.79 · 90.8% pctile

What it does

Copart, Inc. stands as a prominent global provider of online vehicle auctions and comprehensive vehicle remarketing services. The company extends its operations across numerous international markets, including the United States, the United Kingdom, Germany, Brazil, Canada, the United Arab Emirates, Spain, Finland, Oman, the Republic of Ireland, and Bahrain. At its core, Copart enables the buying and selling of vehicles over the internet through its sophisticated "virtual bidding" online auction platform.

Doubt & mispricing

The market doubts it (score 0.92): trading cheap versus its own multi-year range; down 43% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -43.3% (skim recent headlines + the last earnings call).

Notable: the balance sheet holds net cash, which de-risks the wait.

Recent news

5. ADSK Autodesk, Inc.

DOUBT = SENTIMENT

Software - Application · adj close 208.58 (div-adj)

Quality 87.4% pctile
Market doubt 0.85 / 1.00

News read — the doubt looks like sentiment, not damage: Russell index shift is mechanical rebalancing; MaintainX acquisition is accretive; no fundamental damage.. Lifts the opportunity score to 0.87 (from 0.74).

Business quality fingerprint

Returns
ROIC18.7%
ROE36.9%
Gross profitability52.6%
Margins
Gross margin91.0%
Operating margin24.9%
FCF margin33.4% (FCF+)
Growth (3-yr)
Revenue CAGR12.9%
EPS CAGR11.4%
Balance sheet
Net debt / EBITDA0.27
Share count (5-yr)-3.2%
Quality score0.76 · 87.4% pctile

What it does

Autodesk, Inc. delivers advanced software and services for 3D design, engineering, and entertainment to a global clientele. Their diverse product line includes AutoCAD Civil 3D, a comprehensive solution for civil engineering tasks such as land development, transportation infrastructure, and environmental projects. For construction project management, they offer BIM 360, a cloud-based platform.

Doubt & mispricing

The market doubts it (score 0.85): trading cheap versus its own multi-year range; down 36% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -36.2% (skim recent headlines + the last earnings call).

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

6. IDXX IDEXX Laboratories, Inc.

DOUBT = SENTIMENT

Medical - Diagnostics & Research · adj close 558.60 (div-adj)

Quality 98.2% pctile
Market doubt 0.77 / 1.00

News read — the doubt looks like sentiment, not damage: Valuation comparison, price-target gap, and daily underperformance. No fundamental deterioration or catalyst.. Lifts the opportunity score to 0.79 (from 0.75).

Business quality fingerprint

Returns
ROIC40.3%
ROE66.0%
Gross profitability79.4%
Margins
Gross margin61.8%
Operating margin31.6%
FCF margin24.5% (FCF+)
Growth (3-yr)
Revenue CAGR8.5%
EPS CAGR17.7%
Balance sheet
Net debt / EBITDA0.61
Share count (5-yr)-6.8%
Quality score0.89 · 98.2% pctile

What it does

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments.

Doubt & mispricing

The market doubts it (score 0.77): trading cheap versus its own multi-year range; down 27% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.

Recommended next step

HOLD OFF — CONFIRM THE TURN

The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

7. INTU Intuit Inc.

DEBATED

Software - Application · adj close 273.38 (div-adj)

Quality 78.8% pctile
Market doubt 1.00 / 1.00

News read — a real but unresolved debate — no clear damage yet: Management narrative shift on growth strategy; unresolved question about portfolio repositioning and flagship product viability.. Leaves the opportunity score about unchanged.

Business quality fingerprint

Returns
ROIC14.8%
ROE19.6%
Gross profitability41.1%
Margins
Gross margin80.8%
Operating margin26.1%
FCF margin32.3% (FCF+)
Growth (3-yr)
Revenue CAGR14.0%
EPS CAGR23.4%
Balance sheet
Net debt / EBITDA0.64
Share count (5-yr)+3.7%
Quality score0.69 · 78.8% pctile

What it does

Intuit Inc. delivers a comprehensive array of financial management and regulatory compliance solutions, serving individual consumers, small businesses, independent contractors, and accounting professionals across the United States, Canada, and various international markets. The company's operations are structured into four primary divisions: Small Business & Self-Employed, Consumer, Credit Karma, and ProConnect. The Small Business & Self-Employed segment offers the popular QuickBooks ecosystem, which includes cloud-based solutions like QuickBooks Online Advanced, Self-Employed, Commerce (for…

Doubt & mispricing

The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 66% from its 1-year high, below its 200-day line.

Recommended next step

RESEARCH THE CAUSE FIRST

It's both cheap vs its own 5-yr range AND down hard — find out WHY. Read the latest 10-K/10-Q on SEC EDGAR (sec.gov/edgar) and the most recent earnings-call transcript; separate a temporary stumble from a structural problem before treating the discount as opportunity.

Recent news

8. ISRG Intuitive Surgical, Inc.

NEWS CONSTRUCTIVE

Medical - Devices · adj close 411.55 (div-adj)

Quality 91.2% pctile
Market doubt 0.78 / 1.00

News read — the news is constructive: BMO Capital Markets initiates coverage, names ISRG top MedTech pick; upgrade signal with no hard negatives.. Lifts the opportunity score to 0.78 (from 0.71).

Business quality fingerprint

Returns
ROIC13.7%
ROE16.0%
Gross profitability32.2%
Margins
Gross margin66.0%
Operating margin29.3%
FCF margin24.7% (FCF+)
Growth (3-yr)
Revenue CAGR17.4%
EPS CAGR29.2%
Balance sheet
Net debt / EBITDA-0.77
Share count (5-yr)-0.8%
Quality score0.80 · 91.2% pctile

What it does

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach.

Doubt & mispricing

The market doubts it (score 0.78): trading cheap versus its own multi-year range; down 31% from its 1-year high, below its 200-day line.

Recommended next step

BUY CANDIDATE — WORTH A CLOSE LOOK

Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -30.6% (skim recent headlines + the last earnings call).

Notable: the balance sheet holds net cash, which de-risks the wait.

Recent news

9. CLX The Clorox Company

DOUBT = SENTIMENT

Household & Personal Products · adj close 93.07 (div-adj)

Quality 85.8% pctile
Market doubt 0.82 / 1.00

News read — the doubt looks like sentiment, not damage: Management change announcement, stock weakness, and valuation pullback with no fundamental damage or earnings miss.. Lifts the opportunity score to 0.78 (from 0.71).

Business quality fingerprint

Returns
ROIC24.1%
ROE252.3%
Gross profitability57.8%
Margins
Gross margin45.2%
Operating margin16.6%
FCF margin10.7% (FCF+)
Growth (3-yr)
Revenue CAGR-0.0%
EPS CAGR20.5%
Balance sheet
Net debt / EBITDA1.96
Share count (5-yr)-2.4%
Quality score0.75 · 85.8% pctile

What it does

The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley.…

Doubt & mispricing

The market doubts it (score 0.82): trading cheap versus its own multi-year range; down 26% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.

Recommended next step

HOLD OFF — CONFIRM THE TURN

The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

10. AOS A. O. Smith Corporation

DOUBT = SENTIMENT

Industrial - Machinery · adj close 59.02 (div-adj)

Quality 89.8% pctile
Market doubt 0.82 / 1.00

News read — the doubt looks like sentiment, not damage: Leadership transition announced; no earnings miss, guidance cut, or fundamental damage reported. Pure sentiment/noise.. Lifts the opportunity score to 0.77 (from 0.74).

Business quality fingerprint

Returns
ROIC23.9%
ROE29.4%
Gross profitability47.3%
Margins
Gross margin38.8%
Operating margin19.0%
FCF margin14.3% (FCF+)
Growth (3-yr)
Revenue CAGR0.7%
EPS CAGR36.7%
Balance sheet
Net debt / EBITDA0.02
Share count (5-yr)-13.3%
Quality score0.79 · 89.8% pctile

What it does

A. O. Smith Corporation (AOS) is a global manufacturer and marketer specializing in a comprehensive array of water heating and treatment solutions. Its operations span North America, China, Europe, and India, organized into two primary geographic segments: North America and Rest of World.

Doubt & mispricing

The market doubts it (score 0.82): trading cheap versus its own multi-year range; down 26% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.

Recommended next step

HOLD OFF — CONFIRM THE TURN

The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.

Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.

Recent news

How to read this report

improving   deteriorating   flat — direction over the 3-year window

Verdict labels

  • News constructive a real positive catalyst — score lifted
  • Doubt = sentiment the drop looks like noise, not damage — score kept or lifted
  • Debated a real but unresolved question — score about unchanged
  • Doubt earned realized deterioration — score cut; possible value trap
  • Opportunity high quality + high doubt (no news verdict yet)

Key terms

  • Quality %ile how the business ranks on durable quality vs the universe (higher is better)
  • Doubt score how much the market doubts it — cheap vs its own history plus beaten-down on price (0–1)
  • Opportunity high on both quality and doubt — the zone worth investigating
  • Recommended next step a research action for your own judgment — not investment advice
Not investment advice. Transformation Atlas — Research-Based Intelligence. Point-in-time research evidence for human judgment only; not investment advice and not a recommendation to buy or sell any security. Verify each setup independently before acting.